New cancer clinical trial: Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Published on: March 29, 2018 at 12:00PM
Condition:   Non-Small Cell Lung Cancer Stage
Intervention:   Drug: Compound 121564
Sponsors:   Arafat Tfayli;   Merck KGaA;   Phoenix Clinical Research
Not yet recruiting
https://ift.tt/2GMot9G